GemPharmatech provides one-stop solution for production, distribution, phenotyping and contract research of genetically engineered mouse models (GEMMs) for partners across the world. Using advanced gene editing technology, GemPharmatech has created a collection of over 17,000 GEMMs for therapeutic applications such as immuno-oncology, metabolism, cardiovascular diseases, neurodegeneration and rare diseases. We serve the biotechnology and pharmaceutical industry as well as academic and government research institutions.
We specialize in generating mouse models using CRISPR-Cas9 technology. The GPT collection includes conditional knockout (cKO) and knockout (KO), humanized, immunodeficient, and germfree mice. In addition, GPT provides model customization, breeding, phenotyping, and pharmacology services including drug efficacy testing, pharmacokinetics, and safety evaluation.
Wednesday, 18th November, 2020
10:00am GMT (UTC+0)
hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner